ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-PO1123

Patient Survival After Kidney Transplantation: Important Role of Graft-Sustaining Factors as Determined by Predictive Modeling Using Random Survival Forest Analysis

Session Information

Category: Transplantation

  • 1902 Transplantation: Clinical

Authors

  • Scheffner, Irina, Hannover Medical School, Hannover, Germany
  • Gietzelt, Matthias, Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Braunschweig and Hannover, Germany
  • Abeling, Tanja, Hannover Medical School, Hannover, Germany
  • Marschollek, Michael, Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Braunschweig and Hannover, Germany
  • Gwinner, Wilfried, Hannover Medical School, Hannover, Germany
Background

Identification of the relevant factors for death can improve patient’s individual risk assessment and decision making. A well-documented patient cohort (n=892) in a renal transplant program with protocol biopsies was used to establish multivariable models for risk assessment at 3 and 12 months posttransplantation by random survival forest analysis.

Methods

Patients transplanted between 2000 and 2007 were observed up to 11 years. Loss to follow-up was negligible (n=15). 2251 protocol biopsies and 1214 biopsies for cause were performed. All rejections and clinical borderline rejections in protocol biopsies were treated.

Results

10-year patient survival was 78%, with inferior survival of patients with graft loss. Using all pre- and posttransplant variables until 3 and 12 months (n=65), the obtained models showed good performance to predict death (concordance index: 0.77-0.78). Validation with a separate cohort of patients (n=349) showed a concordance index of 0.76 and good discrimination of risks by the models, despite substantial differences in clinical variables. Random survival forest analysis produced robust models over a wide range of parameter settings. Besides well-established risk factors like age, cardiovascular disease, type 2 diabetes, and graft function, posttransplant urinary tract infection and rejection treatment were important factors. Urinary tract infection and rejection treatment were not specifically associated with death due to infection or malignancy but correlated strongly with inferior graft function and graft loss.

Conclusion

The established models indicate the important areas that need special attention in the care of renal transplant patients, particularly modifiable factors like graft rejection and urinary tract infection.